Equibles does not estimate personal net worth.
Get an email with a short summary when Elevance Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELV alertsMark Kaye is recorded as CFO at Elevance Health, Inc. (ELV). Earlier roles on record: CFO at Moodys Corp (MCO) until September 5, 2023. Elevance Health, Inc. reported in an 8-K filed August 8, 2023 that Mark Kaye was appointed Executive Vice President and Chief Financial Officer, effective November 1, 2023. Moodys Corp reported in an 8-K filed August 3, 2023 that Mark Kaye resigned as Executive Vice President and Chief Financial Officer, effective September 5, 2023. The proxy statement of Elevance Health, Inc. reports total compensation of $7,992,077 for Mark Kaye in fiscal 2025, including a base salary of $938,462. Disclosed compensation is on record for 8 fiscal years. Mark Kaye has spoken on 22 earnings calls and 2 other investor events across 2 companies, most recently for Elevance Health, Inc. on October 21, 2026. Those appearances were for Moodys Corp (MCO) and Elevance Health, Inc. (ELV). Elevance Health, Inc. is classified in the Healthcare Plans industry within the Healthcare sector. Other companies whose calls Mark Kaye spoke on are classified in the Financial Services sector. Other leadership on record at Elevance Health, Inc. includes Mark B. Kaye (CFO), Ronald W. Penczek (Chief Accounting Officer), Amy W. Schulman (Board Member) and 3 others.
“On August 8, 2023, Elevance Health, Inc. (the "Company") announced that Mark Kaye has been named Executive Vice President and Chief Financial Officer ("CFO") of the Company, effective November 1, 2023 (the "Transition Date").”
“On August 2, 2023, Mark Kaye submitted his resignation as the Executive Vice President and Chief Financial Officer of Moody's Corporation (the "Company"), effective as of September 5, 2023.”
“Third quarter adjusted diluted earnings per share of $6.99 exceeded our outlook. Improved operating performance across the enterprise supports both our increased 2026 earnings guidance and a higher earnings baseline as we enter 2027.”
“So firstly, a big thank you, Steve, to yourself and to Wells Fargo for having us. I think that's a great starting point for the conversation today.”
“Elevante Health reported second quarter adjusted diluted earnings per share of $7.45, which exceeded our outlook.”
“Scott, good morning, and just a big thank you from both Felicia and I for hosting us at the Goldman Conference today. We're very pleased to be here. We are encouraged by the progress we've made with CMS and the clearer path we now have towards resolution.”
“AJ, good morning, and thank you very much for that question. Briefly, I would say the fourth quarter medical cost performance across the health benefits segment came in generally in line to slightly better than our expectations.”
Start not stated–2023-09-05
Healthcare Plans · Healthcare
CFO
MCO
Financial Data & Stock Exchanges · Financial Services
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Elevance Health, Inc. (ELV) | EVP and Chief Financial Officer (CFO) | $938,462 | $7,992,077 |
| 2024 | Elevance Health, Inc. (ELV) | EVP and Chief Financial Officer (CFO) | $900,000 | $6,873,144 |
| 2023 | Elevance Health, Inc. (ELV) | EVP and Chief Financial Officer (CFO) | $252,692 | $14,859,201 |
| 2022 | Moodys Corp (MCO) | Executive Vice President and Chief Financial Officer | $709,872 | $4,241,491 |
| 2021 | Moodys Corp (MCO) | Executive Vice President and Chief Financial Officer | $575,000 | $4,180,748 |
| 2020 | Moodys Corp (MCO) | Senior Vice President and Chief Financial Officer | $562,500 | $4,103,702 |
| 2019 | Moodys Corp (MCO) | Senior Vice President and Chief Financial Officer | $525,000 | $2,841,911 |
| 2018 | Moodys Corp (MCO) | Senior Vice President and Chief Financial Officer | $192,837 | $3,368,222 |
